MMSL 2022, 91(1):11-17 | DOI: 10.31482/mmsl.2021.028

PREVALENCE OF ANEMIA AND ITS IMPACT ON THE QUALITY OF LIFE OF RENAL TRANSPLANT RECIPIENTS: A CROSS-SECTIONAL STUDYOriginal article

Sireen Abdul Rahim Shilbayeh ORCID...
Department of Pharmaceutical Practice, College of Pharmacy, Princess Nourah bint Abdulrahman University (PNU)

Background: Renal transplant patients show a high incidence of anemia, which is often responsible for cardiovascular morbidity and graft rejection. Anemia reportedly impacts the health-related quality of life (HRQoL); however, only a limited number of related studies have been conducted on renal transplant recipients. In this study, we estimated the prevalence of anemia and its effects on QoL of renal transplant patients in Saudi Arabia.

Methods: Seventy-four patients were recruited in this study. They were asked to fill a self-reported EuroQoL instrument (EQ-5D-5L). We measured the hemoglobin levels (Hgb) of the patients to assess their anemia status. Anemia and severe anemia were defined as Hgb < 12 g/dL and Hgb < 10 g/dL, respectively.

Results: Of the 74 recruited patients, 53 patients (71.6%) were anemic. Around 33.7% patients were reported to be completely healthy, with a 5-digit of 11111. With respect to EQ-5D-5L, the responses of anemic and non-anemic patients did not differ significantly. However, the response to anxiety-related questions for patients belonging to severe and mild-to-moderate anemia groups differed significantly. The final multivariate logistic model analysis revealed that the gender of patient was significantly associated with incidence of anemia postoperatively [OR: 6.72, 95% CI: 1.7 - 25.6, P-value = 0.000; (25 males, 47.2%) vs. (28 females, 52.9%)]. The use of intravenous (IV) immunoglobulin in the induction phase was significantly associated with incidence of late anemia [P-value = 0.012].

Conclusions: Interestingly, our findings revealed a higher prevalence of anemia among the Saudi kidney patients compared to those of other nations. The incidence of anemia was shown to be significantly associated with renal function, female gender, and IV immunoglobulin use at the induction phase. Furthermore, multicentric prospective studies are warranted to elucidate other clinical factors that are associated with anemia and the underlying pathophysiological mechanisms.

Keywords: Anemia; post-transplant; quality of life; renal; Saudi

Received: September 3, 2021; Revised: September 3, 2021; Accepted: September 20, 2021; Prepublished online: October 25, 2021; Published: March 4, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Shilbayeh, S.A.R. (2022). PREVALENCE OF ANEMIA AND ITS IMPACT ON THE QUALITY OF LIFE OF RENAL TRANSPLANT RECIPIENTS: A CROSS-SECTIONAL STUDY. MMSL91(1), 11-17. doi: 10.31482/mmsl.2021.028
Download citation

References

  1. Al-Sayyari AA and Shaheen FA. End stage chronic kidney disease in Saudi Arabia. Saudi Medical Journal. 2011;32(4):339-346.
  2. Bielesz B, Reiter T, Hammerle FP, et al. The Role of Iron and Erythropoietin in the Association of Fibroblast Growth Factor 23 with Anemia in Chronic Kidney Disease in Humans. Journal of Clinical Medicine. 2020;9(8):2640. Go to original source... Go to PubMed...
  3. Abaci SH, Alagoz S, Salihoglu A, et al. December. Assessment of Anemia and quality of life in patients with renal transplantation. In Transplantation proceedings. 2015;47(10):2875-2880. Go to original source... Go to PubMed...
  4. Yabu JM and Winkelmayer WC. Posttransplantation anemia: mechanisms and management. Clinical Journal of the American Society of Nephrology. 2011;6(7):1794-1801. Go to original source... Go to PubMed...
  5. Ross SD, Fahrbach K, Frame D, et al. The effect of anemia treatment on selected health-related quality-of-life domains: a systematic review. Clinical Therapeutics. 2003;25(6):1786-1805. Go to original source... Go to PubMed...
  6. Ando K, Morita S, Higashi T, et al. Health-related quality of life among Japanese women with iron-deficiency anemia. Quality of life research. 2006;15(10):1559-1563. Go to original source... Go to PubMed...
  7. Staibano P, Perelman I, Lombardi J, et al. Patient-centered outcomes in the management of anemia: A scoping review. Transfusion medicine reviews. 2019;33(1):7-11. Go to original source... Go to PubMed...
  8. Ichimaru N, Obi Y, Nakazawa S, et al. April. Post-transplant Anemia has strong influences on renal and patient outcomes in living kidney transplant patients. In Transplantation Proceedings. 2016;48(3):878-883. Go to original source... Go to PubMed...
  9. Huang Z, Song T, Fu L, et al. Post-renal transplantation anemia at 12 months: prevalence, risk factors, and impact on clinical outcomes. International urology and nephrology. 2015;47(9):1577-1585. Go to original source... Go to PubMed...
  10. Herdman M, Gudex C, Lloyd A, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Quality of life research. 2011;20(10):1727-1736. Go to original source... Go to PubMed...
  11. Markvardsen LH, Christiansen I, Harbo T, et al. 2014. Hemolytic anemia following high dose intravenous immunoglobulin in patients with chronic neurological disorders. European Journal of Neurology. 2014;21(1):147-152. Go to original source... Go to PubMed...
  12. Elsayed H, Sany D, Eldin EN, et al. Prevalence and association of post-renal transplant anemia. Saudi Journal of Kidney Diseases and Transplantation. 2012;23(3):461-466. Go to PubMed...